What are the maximum single‑dose limits and maximum weekly dosing frequencies for intravenous iron preparations (iron sucrose [Venofer], ferric gluconate [Ferrlecit], low‑molecular‑weight iron dextran [INFeD/Dexferrum], ferric carboxymaltose [Ferinject/Injectafer], ferumoxytol [Feraheme])?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose and Frequency of Intravenous Iron

The maximum single dose and weekly frequency of IV iron depends on the specific formulation: ferric carboxymaltose and ferumoxytol allow up to 1000 mg per week, iron sucrose permits 200-500 mg per dose (typically 200 mg), ferric gluconate is limited to 125 mg per dose, and low-molecular-weight iron dextran can be given as a total dose infusion but requires 4-6 hours. 1, 2, 3

Ferric Carboxymaltose (Ferinject/Injectafer)

This is the most practical formulation for rapid iron repletion in most clinical scenarios.

Maximum Dosing Parameters

  • Maximum single dose: 1000 mg iron per administration 1, 4
  • Maximum weekly dose: 1000 mg iron per week 5, 1
  • Administration time: 15-30 minutes (can be given as undiluted IV push over 15 minutes or diluted in 100-250 mL normal saline) 1, 4

Practical Dosing Algorithm

For patients requiring >1000 mg total iron deficit:

  • Administer doses separated by at least 7 days 1
  • Typical regimen: 1000 mg Day 1, then 500-1000 mg at Week 1 (depending on body weight and hemoglobin) 1

Critical Safety Thresholds

  • Do not administer if hemoglobin >15 g/dL 1
  • Mandatory 30-minute post-infusion observation for hypersensitivity reactions 1
  • Avoid in active bacteremia – discontinue treatment if infection develops 1

Important Monitoring Caveat

  • Do not recheck iron parameters within 4 weeks of administration, as ferritin will be falsely elevated 1
  • Reassess iron status at 3 months after initial treatment 1
  • Monitor serum phosphate in patients requiring repeat courses within 3 months, as hypophosphatemia occurs in 47-75% of such cases 1, 6

Iron Sucrose (Venofer)

This formulation requires multiple visits but has an excellent safety profile with no test dose required.

Maximum Dosing Parameters

  • Maximum single dose: 200 mg per administration (some guidelines allow up to 500 mg over 3.5 hours in IBD patients, but 200 mg is standard) 5, 2
  • Administration time: 10 minutes as IV push (undiluted) for 200 mg doses 2
  • Frequency: Can be given 2-3 times weekly in hemodialysis patients 2

Practical Considerations

  • No test dose required (unlike iron dextran) 2
  • Requires 5-10 infusions to deliver 1000-2000 mg total iron deficit 5
  • Most practical for hemodialysis patients where it can be administered directly into the dialysis line 2

Monitoring Intervals

  • Allow at least 7 days before rechecking iron parameters after 200 mg doses 2
  • Monitor iron studies every 3 months during maintenance therapy 2

Ferric Gluconate (Ferrlecit)

This is the most limited formulation but remains cost-effective for hemodialysis patients.

Maximum Dosing Parameters

  • Maximum single dose: 125 mg per infusion 3
  • Administration time: 60 minutes (infused in 50-100 mL saline) 3
  • Standard regimen: 125 mg weekly for 8 consecutive weeks (total 1000 mg) 3

Key Advantages

  • No test dose required (unlike iron dextran) 3
  • Lowest cost: approximately $610 for 1000 mg total dose vs. $3,470 for ferric carboxymaltose 3
  • No reported fatalities in clinical use 3

When to Choose Ferric Gluconate

  • Hemodialysis patients with routine dialysis access 3
  • Patients with cost constraints 3
  • Patients who have had reactions to iron dextran 3

When to Avoid

  • Patients requiring rapid iron repletion (requires 8 weekly visits) 3
  • Patients who cannot return for multiple infusions 3

Low-Molecular-Weight Iron Dextran (INFeD/Dexferrum)

This formulation allows total dose infusion but requires prolonged administration time.

Maximum Dosing Parameters

  • Can administer total calculated iron deficit in single infusion 7, 8
  • Administration time: 4-6 hours for total dose infusion 9, 7
  • Test dose: May be advisable but no longer mandatory 9

Safety Considerations

  • Higher risk of anaphylaxis compared to newer formulations due to larger carbohydrate shell 9
  • Requires prolonged monitoring during extended infusion 7

Ferumoxytol (Feraheme)

This formulation allows rapid high-dose administration but has specific safety concerns.

Maximum Dosing Parameters

  • Standard dosing: 510 mg per dose, given as two doses separated by 3-8 days 7
  • Administration time: Can be given rapidly 7
  • Total course: 1020 mg over 1-2 weeks 7

Important Safety Note

  • Higher risk of anaphylaxis due to larger carbohydrate shell (similar to iron dextran) 9
  • Requires appropriate emergency preparedness 7

Iron Isomaltoside 1000

This formulation is available in Europe and allows high single doses.

Maximum Dosing Parameters

  • Maximum single dose: 20 mg/kg body weight (up to 1000 mg) 5
  • Minimum infusion time: 15 minutes for doses up to 1000 mg; >30 minutes if dose exceeds 1000 mg 5

Common Pitfalls to Avoid Across All Formulations

  1. Premature iron studies: Do not measure ferritin or TSAT within 4 weeks of IV iron administration – values will be falsely elevated and mask inadequate repletion 1, 3

  2. Underdosing with single infusions: A single 1000 mg ferric carboxymaltose infusion frequently fails to achieve complete iron repletion; most patients require 1500-2000 mg total 1

  3. Concurrent oral iron: Do not use oral iron simultaneously with IV iron – it increases side effects without additional benefit 3

  4. Ignoring infection: Withhold IV iron in patients with active bacteremia or ongoing infection 1, 2

  5. Exceeding hemoglobin threshold: Do not administer any IV iron formulation when hemoglobin >15 g/dL 1

  6. Inadequate observation: All IV iron formulations require at least 30 minutes of post-infusion monitoring in a facility equipped to manage hypersensitivity reactions 1, 3

Algorithm for Formulation Selection

Choose ferric carboxymaltose or ferumoxytol when:

  • Rapid iron repletion needed (1-2 visits) 1, 7
  • Patient cannot return for multiple visits 1
  • Total iron deficit >1000 mg 1

Choose iron sucrose when:

  • Patient is on hemodialysis with routine access 2
  • Gradual repletion is acceptable 2
  • Intermediate cost consideration 2

Choose ferric gluconate when:

  • Patient is on hemodialysis 3
  • Cost is primary concern 3
  • Patient had prior reaction to iron dextran 3

Avoid iron dextran unless:

  • Total dose infusion is specifically required 7
  • Patient can tolerate 4-6 hour infusion 9
  • Other formulations are unavailable 7

References

Guideline

Administration of Ferric Carboxymaltose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Intravenous Iron Sucrose Administration for Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ferric Gluconate Dosing for Severe Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Oral and Intravenous Iron Therapy.

Advances in experimental medicine and biology, 2025

Research

The available intravenous iron formulations: History, efficacy, and toxicology.

Hemodialysis international. International Symposium on Home Hemodialysis, 2017

Research

Intravenous iron therapy: how far have we come?

Revista brasileira de hematologia e hemoterapia, 2011

Related Questions

What is the dose and duration of iron repletion therapy for a patient with iron deficiency anemia, given lab results showing elevated Iron Binding Capacity (Total Iron Binding Capacity), low percent saturation, and low ferritin levels?
What is the recommended dose of intravenous (IV) iron?
What are the brand‑name iron preparations (including their generic names) for oral and intravenous therapy?
What is the recommended dosing and administration of Ferrex‑150 (polysaccharide‑iron complex) for adults and children?
What is the appropriate dose of intravenous iron for a piggyback infusion in an adult?
What is the appropriate evaluation and management for a 1‑year‑old child with an elevated monocyte count?
What is the most likely diagnosis and appropriate emergency management for a patient with epigastric pain, three episodes of vomiting, obstipation for three days (but passed flatus three times yesterday), hyperactive bowel sounds and no abdominal rigidity?
Can hydroxyzine cause QT interval prolongation and arrhythmias, particularly in elderly patients or those with pre‑existing cardiac disease, electrolyte disturbances, or concomitant QT‑prolonging medications?
Which vitamin or mineral supplements are contraindicated when taking doxycycline?
When obtaining blood cultures and an arterial blood gas sample, which should be drawn first, and should the aerobic bottle be filled before the anaerobic bottle?
What is crepitus, its clinical significance, and how should it be evaluated and managed in an adult patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.